Vitamin Shoppe (NYSE: VSI ) is expected to report Q2 earnings on Aug. 6. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Vitamin Shoppe's revenues will expand 15.9% and EPS will grow 9.1%.
The average estimate for revenue is $284.0 million. On the bottom line, the average EPS estimate is $0.60.
Last quarter, Vitamin Shoppe logged revenue of $279.1 million. GAAP reported sales were 13% higher than the prior-year quarter's $248.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, non-GAAP EPS came in at $0.72. GAAP EPS of $0.68 for Q1 were 11% higher than the prior-year quarter's $0.61 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 36.4%, 80 basis points better than the prior-year quarter. Operating margin was 13.1%, 80 basis points better than the prior-year quarter. Net margin was 7.5%, 10 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $1.10 billion. The average EPS estimate is $2.29.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 52 members out of 64 rating the stock outperform, and 12 members rating it underperform. Among 28 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 19 give Vitamin Shoppe a green thumbs-up, and nine give it a red thumbs-down.
Is Vitamin Shoppe the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.
- Add Vitamin Shoppe to My Watchlist.